Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity.
作者信息
Chetty Ashwin K, Khunte Mihir, Chen Alissa S, Jastreboff Ania M, Krumholz Harlan M, Lu Yuan
机构信息
Yale School of Medicine, New Haven, CT, USA.
Warren Alpert Medical School of Brown University, Providence, RI, USA.
出版信息
J Gen Intern Med. 2025 May;40(6):1467-1469. doi: 10.1007/s11606-024-09178-8. Epub 2024 Oct 30.
Abstract
摘要
相似文献
1
Eligibility for Anti-Obesity Medications Among Medicare Beneficiaries with Overweight or Obesity.医疗保险超重或肥胖受益人群使用抗肥胖药物的资格
J Gen Intern Med. 2025 May;40(6):1467-1469. doi: 10.1007/s11606-024-09178-8. Epub 2024 Oct 30.
2
Racial and Ethnic Disparities in Health Care Use and Access Associated With Loss of Medicaid Supplemental Insurance Eligibility Above the Federal Poverty Level.医疗保健使用和获得方面的种族和族裔差异与超过联邦贫困水平的医疗补助补充保险资格丧失有关。
JAMA Intern Med. 2023 Jun 1;183(6):534-543. doi: 10.1001/jamainternmed.2023.0512.
3
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation Study.《降低通胀法案》下患有痴呆症的医疗保险受益人的自付药品费用变化：一项模拟研究
Value Health. 2025 Apr;28(4):553-561. doi: 10.1016/j.jval.2025.01.008. Epub 2025 Jan 27.
4
Antiretroviral Therapy Use and Disparities Among Medicare Beneficiaries with HIV.抗逆转录病毒疗法的使用与艾滋病毒医疗保险受益人的差异。
J Gen Intern Med. 2024 Sep;39(12):2196-2205. doi: 10.1007/s11606-024-08847-y. Epub 2024 Jun 12.
5
Use of Multiplex Molecular Panels to Diagnose Urinary Tract Infection in Older Adults.使用多重分子面板诊断老年人尿路感染。
JAMA Netw Open. 2024 Nov 4;7(11):e2446842. doi: 10.1001/jamanetworkopen.2024.46842.
6
Effects of Medicare Eligibility at Age 65 Among Individuals With and Without Functional Disability.65岁时医疗保险资格对有或无功能残疾个体的影响。
J Gen Intern Med. 2025 Apr;40(5):1132-1140. doi: 10.1007/s11606-024-09060-7. Epub 2024 Oct 4.
7
The association between rurality, dual Medicare/Medicaid eligibility and chronic conditions with telehealth utilization: An analysis of 2019-2020 national Medicare claims.农村地区、医疗保险/医疗补助双重资格与慢性病和远程医疗使用之间的关联：对2019 - 2020年全国医疗保险索赔的分析
J Telemed Telecare. 2024 Feb 5:1357633X241226741. doi: 10.1177/1357633X241226741.
8
The Medicare Care Choices Model was associated with reductions in disparities in the use of hospice care for Medicare beneficiaries with terminal illness.医疗保险护理选择模式与减少终末期疾病的医疗保险受益人在使用临终关怀服务方面的差异有关。
Health Serv Res. 2024 Aug;59(4):e14289. doi: 10.1111/1475-6773.14289. Epub 2024 Feb 29.
9
Incident Epilepsy Among US Medicare Beneficiaries, 2019: Differences by Age, Sex, and Race/Ethnicity.美国医疗保险受益人群中 2019 年的癫痫发作事件：按年龄、性别和种族/族裔划分的差异。
Neurology. 2024 Oct 8;103(7):e209804. doi: 10.1212/WNL.0000000000209804. Epub 2024 Sep 9.
10
Out-of-Pocket Prescription Drug Savings for Medicare Beneficiaries with Asthma and COPD Under the Inflation Reduction Act.《降低通胀法案》下哮喘和慢性阻塞性肺疾病医疗保险受益人的自付处方药节省费用情况
J Gen Intern Med. 2025 Apr;40(5):1141-1149. doi: 10.1007/s11606-024-09063-4. Epub 2024 Oct 4.
本文引用的文献
1
Prevalence of Cardiometabolic Diseases Among Racial and Ethnic Subgroups in Adults - Behavioral Risk Factor Surveillance System, United States, 2013-2021.2013 - 2021年美国成年人种族和族裔亚组中心血管代谢疾病的患病率 - 行为危险因素监测系统
MMWR Morb Mortal Wkly Rep. 2024 Jan 25;73(3):51-56. doi: 10.15585/mmwr.mm7303a1.
2
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.司美格鲁肽在肥胖但无糖尿病患者中的心血管结局。
N Engl J Med. 2023 Dec 14;389(24):2221-2232. doi: 10.1056/NEJMoa2307563. Epub 2023 Nov 11.
3
Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey.基于SELECT试验标准的美国心血管疾病风险降低治疗资格：来自国家健康与营养检查调查的见解
Circ Cardiovasc Qual Outcomes. 2024 Jan;17(1):e010640. doi: 10.1161/CIRCOUTCOMES.123.010640. Epub 2023 Nov 11.
4
Medicare Part D Coverage of Antiobesity Medications - Challenges and Uncertainty Ahead.医疗保险D部分对减肥药的覆盖范围——前方的挑战与不确定性
N Engl J Med. 2023 Mar 16;388(11):961-963. doi: 10.1056/NEJMp2300516. Epub 2023 Mar 11.
Zotero 插件